Leica Biosystems Inc.

32 articles about Leica Biosystems Inc.

• Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel

  4/3/2023

  Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers with a high-performing IHC Mismatch Repair (MMR) option when screening colorectal cancer patients for the identification of probable Lynch syndrome.

• Leica Biosystems Acquires Cell IDx, Moving its Multiplexing Menu Forward with Ready-to-Use, Pre-Kitted Formulations

  11/8/2022

  Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling.

• Leica Biosystems Announces Partnership with Indica Labs to Deliver Integrated Digital Pathology Workflow Solutions for Mutual Customers

  9/6/2022

  Leica Biosystems announced a partnership focused on delivering compatible digital pathology workflow solutions.

• Leica Biosystems New Advanced Staining Solution Transcends Expectations with Speed, Quality and Diagnostic Productivity

  5/19/2022

  Leica Biosystems is launching BOND-PRIME, a premium Advanced Staining solution, to advance diagnostic productivity in the lab.

• NanoString Expands Partnership with Leica Biosystems to Accelerate Spatial Discoveries with Automated Workflow

  2/23/2022

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the release of a fully automated GeoMx® RNA protocol on BOND RX research staining systems through an expanded partnership with Leica Biosystems.

• 

  Life Sciences Companies Leverage New Partnerships Against Severe Diseases

  2/1/2022

  Various pharmaceutical companies announced collaborations and licensing agreements from January 31 to February 1. 

• Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer Patients

  1/31/2022

  Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (NASDAQ: LPTX), a biotechnology company, to develop a companion diagnostic to detect Dickkopf-related protein 1 (DKK1).

• Paige and Leica Biosystems Partner to Expand Access to Computational Pathology Products for Pathology and Oncology Research

  4/22/2021

  Companies to offer Paige’s machine learning technologies via Leica Biosystems digital pathology platform to offer advanced end-to-end digital pathology workflow solutions

• Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope In Situ Hybridization Detection Kit

  5/26/2020

  Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities and Leica Biosystems, a global leader in workflow solutions and automation, are proud to announce the European launch of the CE-IVD marked RNAscope™ In Situ Hybridization Detection Kit for automation on the BOND-III platform.

• FDA Expands Leica Biosystems Enforcement Discretion Enabling Remote Diagnosis Using Aperio WebViewer and Aperio AT2 Scanners During COVID-19 Crisis

  4/24/2020

   Leica Biosystems, the global leader in pathology workflow solutions, today announced it has received additional notification from the U.S. Food & Drug Administration (FDA) about its intention to exercise enforcement discretion when the Aperio WebViewer, a web-based viewing software within Aperio eSlide Manager , is used for remo

• Leica Biosystems Receives FDA's Enforcement Discretion For Use Of Aperio ImageScope DX Viewing Software For Remote Diagnosis During COVID-19 Emergency

  4/3/2020

  Leica Biosystems, the global leader in pathology workflow solutions, today announced it has received notification from the U.S. Food & Drug Administration (FDA) that its Aperio ImageScope DX Viewer with images acquired on the Aperio AT2 DX Scanner can be used for remote diagnosis under emergency use.

• Transforming Conventional to Digital Pathology, Leica Biosystems Introduces Case Management Software to Support Aperio AT2 DX System for Primary Diagnosis

  3/2/2020

  Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today announced a significant development for anatomical pathology laboratories by bringing together its Aperio AT2 DX System—digital pathology whole slide imaging—with Aperio Path DX web-based, state-of-the-art, case management software.

• Leica Biosystems and Sectra Partner to Pursue FDA Clearance for an Integrated Clinical Digital Pathology Solution

  12/2/2019

  Leica Biosystems, the global leader in pathology workflow solutions, and the international medical imaging IT and cybersecurity company, Sectra, announce a collaboration to seek a combined 510(k) clearance from the U.S. Food & Drug Administration (FDA) in the near future.

• Leica Biosystems Receives FDA 510(k) Clearance to Market a Digital Pathology System for Primary Diagnosis

  5/29/2019

  Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration to market its Aperio AT2 DX System for clinical diagnosis in the U.S.

• Partnership of Leeds Teaching Hospitals NHS Trust with Leica Biosystems Achieves Major Milestone for Cancer Diagnostics

  10/25/2018

  Collaboration to enable large-scale transition from glass slides to digital images for pathology diagnoses across all subspecialties

• For Breast Biopsies, MammoPort Standardizes Tissue Transfer from Radiology to Pathology to Ensure Quality and Reduce Errors

  10/2/2018

  Leica Biosystems, the leader in cancer diagnostics from biopsy to diagnosis, today announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system for breast tissue biopsies, which average 1.6 million a year in the United States alone.

• For High-Volume Pathology Labs, HistoCore SPECTRA Workstation Delivers Immediately Dry Slides at Faster Turnaround Times

  9/18/2018

  Integrating revolutionary technology from Leica Biosystems offers exceptionally high throughput and consistent staining quality to enhance efficiency and diagnostic confidence.

• Rotary Microtome Solutions Provide Pathology Labs High Quality Sectioning and Enhanced User Safety

  5/30/2018

  Leica Biosystems announces the addition of a new family of Rotary Microtomes to its full line of histology equipment and consumables.

• Leica Biosystems to Advance Artificial Intelligence in Pathology as part of UK Life Sciences Sector Deal

  12/22/2017

  This agreement draws substantial investment into the sector including the development of a trail-blazing digital pathology program leveraging AI.

• Clearbridge BioMedics and Leica Biosystems to Co-Market Automated Solutions for Circulating Tumor Cell Analysis

  11/16/2017

  This new partnership provides an integrated and automated workflow for CTC enrichment and immunostaining, improving on major challenges in CTC liquid biopsy testing, such as handling and standardization.